BDBM50070014 (2R,3R)-2-[4-(2,2-Dimethyl-propionyl)-phenoxy]-3-methyl-4-oxo-azetidine-1-carboxylic acid benzylamide::CHEMBL122983

SMILES C[C@@H]1[C@@H](Oc2ccc(cc2)C(=O)C(C)(C)C)N(C(=O)NCc2ccccc2)C1=O

InChI Key InChIKey=IPCPSNUGFLGJAU-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50070014   

TargetCapsid scaffolding protein(HHV-5)
Glaxo Wellcome Research and Development

Curated by ChEMBL
LigandPNGBDBM50070014((2R,3R)-2-[4-(2,2-Dimethyl-propionyl)-phenoxy]-3-m...)
Affinity DataIC50: 1.70E+4nMAssay Description:Concentration required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetAcetylcholinesterase(Human)
Glaxo Wellcome Research and Development

Curated by ChEMBL
LigandPNGBDBM50070014((2R,3R)-2-[4-(2,2-Dimethyl-propionyl)-phenoxy]-3-m...)
Affinity DataIC50: 1.00E+5nMAssay Description:Concentration required to inhibit the mammalian Acetylcholinesterase by 50% was determinedMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetChymotrypsinogen A(Bovine)
Glaxo Wellcome Research and Development

Curated by ChEMBL
LigandPNGBDBM50070014((2R,3R)-2-[4-(2,2-Dimethyl-propionyl)-phenoxy]-3-m...)
Affinity DataIC50: 1.00E+5nMAssay Description:Concentration required to inhibit the mammalian Chymotrypsinogen by 50% was determinedMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed